These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 26234590)

  • 1. A New Role for Clonidine in Addictions: Catching Relapses Before They Happen.
    deWit H
    Am J Psychiatry; 2015 Aug; 172(8):700-1. PubMed ID: 26234590
    [No Abstract]   [Full Text] [Related]  

  • 2. Clonidine Maintenance Prolongs Opioid Abstinence and Decouples Stress From Craving in Daily Life: A Randomized Controlled Trial With Ecological Momentary Assessment.
    Kowalczyk WJ; Phillips KA; Jobes ML; Kennedy AP; Ghitza UE; Agage DA; Schmittner JP; Epstein DH; Preston KL
    Am J Psychiatry; 2015 Aug; 172(8):760-7. PubMed ID: 25783757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detoxification and treating opioid dependence.
    de Jong CJ
    JAMA; 2006 Feb; 295(8):887; author reply 887-8. PubMed ID: 16493098
    [No Abstract]   [Full Text] [Related]  

  • 4. Methods of detoxification and their role in treating patients with opioid dependence.
    O'Connor PG
    JAMA; 2005 Aug; 294(8):961-3. PubMed ID: 16118388
    [No Abstract]   [Full Text] [Related]  

  • 5. Buprenorphine Maintenance vs. Placebo for Opioid Dependence.
    Raleigh MF
    Am Fam Physician; 2017 Mar; 95(5):Online. PubMed ID: 28290640
    [No Abstract]   [Full Text] [Related]  

  • 6. Detoxification and treating opioid dependence.
    Contreras JA
    JAMA; 2006 Feb; 295(8):886-7; author reply 887-8. PubMed ID: 16493097
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparison of pharmacological treatments for opioid-dependent adolescents: a randomized controlled trial.
    Marsch LA; Bickel WK; Badger GJ; Stothart ME; Quesnel KJ; Stanger C; Brooklyn J
    Arch Gen Psychiatry; 2005 Oct; 62(10):1157-64. PubMed ID: 16203961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Buprenorphine in the emergency department: Randomized clinical controlled trial of clonidine versus buprenorphine for the treatment of opioid withdrawal.
    Srivastava A; Kahan M; Njoroge I; Sommer LZ
    Can Fam Physician; 2019 May; 65(5):e214-e220. PubMed ID: 31088887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined buprenorphine and chlonidine for short-term opiate detoxification: patient perspectives.
    Wallen MC; Lorman WJ; Gosciniak JL
    J Addict Dis; 2006; 25(1):23-31. PubMed ID: 16597570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expanded table: Some drugs for management of opioid withdrawal symptoms.
    Med Lett Drugs Ther; 2018 Aug; 60(1554):e144-e146. PubMed ID: 30133422
    [No Abstract]   [Full Text] [Related]  

  • 11. Two methods of community detoxification from opiates: an open-label comparison of lofexidine and buprenorphine.
    White R; Alcorn R; Feinmann C
    Drug Alcohol Depend; 2001 Dec; 65(1):77-83. PubMed ID: 11714592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lofexidine (Lucemyra) for opioid withdrawal.
    Med Lett Drugs Ther; 2018 Jul; 60(1551):115-117. PubMed ID: 30036346
    [No Abstract]   [Full Text] [Related]  

  • 13. Preliminary evidence of different and clinically meaningful opioid withdrawal phenotypes.
    Dunn KE; Weerts EM; Huhn AS; Schroeder JR; Tompkins DA; Bigelow GE; Strain EC
    Addict Biol; 2020 Jan; 25(1):e12680. PubMed ID: 30295400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The emperor' s new clothes.
    Schnoll SH
    J Addict Dis; 2003; 22(4):1-4. PubMed ID: 14723473
    [No Abstract]   [Full Text] [Related]  

  • 15. Buprenorphine/naloxone versus methadone and lofexidine in community stabilisation and detoxification: A randomised controlled trial of low dose short-term opiate-dependent individuals.
    Law FD; Diaper AM; Melichar JK; Coulton S; Nutt DJ; Myles JS
    J Psychopharmacol; 2017 Aug; 31(8):1046-1055. PubMed ID: 28631527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evolving use of buprenorphine in the treatment of addiction.
    Martin J
    J Psychoactive Drugs; 2004 May; Suppl 2():129-37. PubMed ID: 15279125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opioid withdrawal, craving, and use during and after outpatient buprenorphine stabilization and taper: a discrete survival and growth mixture model.
    Northrup TF; Stotts AL; Green C; Potter JS; Marino EN; Walker R; Weiss RD; Trivedi M
    Addict Behav; 2015 Feb; 41():20-8. PubMed ID: 25282598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Convincing effects of clonidine on neurohumoral withdrawal symptoms during antagonist-supported detoxification of opioid addicts.
    White PF; Wender RH
    Anesth Analg; 2003 Nov; 97(5):1548. PubMed ID: 14570693
    [No Abstract]   [Full Text] [Related]  

  • 19. Public policy statement on buprenorphine for opiate dependence and withdrawal.
    J Addict Dis; 2004; 23(4):116-7. PubMed ID: 15534969
    [No Abstract]   [Full Text] [Related]  

  • 20. Anesthesia-assisted vs buprenorphine- or clonidine-assisted heroin detoxification and naltrexone induction: a randomized trial.
    Collins ED; Kleber HD; Whittington RA; Heitler NE
    JAMA; 2005 Aug; 294(8):903-13. PubMed ID: 16118380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.